Add like
Add dislike
Add to saved papers

Preliminary PET/CT Imaging with Somatostatin Analogs [ 68 Ga]DOTAGA-TATE and [ 68 Ga]DOTAGA-TOC.

PURPOSE: Somatostatin receptor positron emission tomography/X-ray computed tomography (SSTR-PET/CT) is a well-established technique for staging and detection of neuroendocrine tumors (NETs). Ga-68-labeled DOTA-conjugated octreotide analogs are the privileged radiotracers for diagnosis and therapeutic monitoring of NETs. Hence, we were interested in assessing the influence of promising, newer variant DOTAGA on the hydrophilicity, pharmacokinetics, and lesion pick-up of somatostatin analogs. Herein, the potential of ([68 Ga]DOTAGA, Tyr3 , Thr8 ) octreotide ([68 Ga]DOTAGA-TATE) and ([68 Ga]DOTAGA, Tyr3 ) octreotide ([68 Ga]DOTAGA-TOC) as NET imaging agents has been investigated.

PROCEDURES: Amenability of [68 Ga]DOTAGA-(TATE/TOC) to kit-type formulation has been demonstrated. Biodistribution studies were carried out in normal rats at 1 h post-injection (p.i.). [68 Ga]DOTAGA-(TATE/TOC) PET/CT scans were carried out in patients (70-170 MBq, 1 h p.i.) with histologically confirmed well-differentiated NETs.

RESULTS: [68 Ga]DOTAGA-TATE exhibited hydrophilicity similar to [68 Ga]DOTA-TATE (log P = -3.51 vs -3.69) whereas [68 Ga]DOTAGA-TOC was more hydrophilic than [68 Ga]DOTA-TOC (log P = -3.27 vs -2.93). [68 Ga]DOTAGA-TATE and [68 Ga]DOTA-TATE showed almost identical blood and kidney uptake in normal rats whereas significantly fast clearance (p < 0.05) of [68 Ga]DOTAGA-TATE was observed from other non-specific organs (liver, lungs, spleen, intestine). [68 Ga]DOTAGA-TOC also demonstrated rapid clearance from blood and kidneys (p < 0.05) in comparison to [68 Ga]DOTA-TOC. The metastatic lesions in NET patients were well identified by [68 Ga]DOTAGA-TATE and [68 Ga]DOTAGA-TOC.

CONCLUSION: The phenomenal analogy was observed between [68 Ga]DOTAGA-TATE and [68 Ga]DOTA-TATE as well as between [68 Ga]DOTAGA-TOC and [68 Ga]DOTA-TOC in biodistribution studies in rats. The good lesion detection ability of the two radiotracers indicates their potential as NET imaging radiotracers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app